BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 18350379)

  • 21. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
    Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
    Fang DD; Kim YJ; Lee CN; Aggarwal S; McKinnon K; Mesmer D; Norton J; Birse CE; He T; Ruben SM; Moore PA
    Br J Cancer; 2010 Apr; 102(8):1265-75. PubMed ID: 20332776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
    Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
    Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell surface Nestin is a biomarker for glioma stem cells.
    Jin X; Jin X; Jung JE; Beck S; Kim H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a GM7 glioblastoma cell line showing CD133 positivity and both cytoplasmic and nuclear localization of nestin.
    Loja T; Chlapek P; Kuglik P; Pesakova M; Oltova A; Cejpek P; Veselska R
    Oncol Rep; 2009 Jan; 21(1):119-27. PubMed ID: 19082452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
    Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
    World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71.
    Matsuda Y; Ishiwata T; Yoshimura H; Hagio M; Arai T
    Cancer Lett; 2015 Feb; 357(2):602-11. PubMed ID: 25527454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.
    Wang J; Sakariassen PØ; Tsinkalovsky O; Immervoll H; Bøe SO; Svendsen A; Prestegarden L; Røsland G; Thorsen F; Stuhr L; Molven A; Bjerkvig R; Enger PØ
    Int J Cancer; 2008 Feb; 122(4):761-8. PubMed ID: 17955491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
    Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
    Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
    Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
    Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
    Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S
    Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
    deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
    Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation.
    Shin GY; Shim JK; Lee JH; Shin HJ; Lee SJ; Huh YM; Kim EH; Park EK; Kim SH; Chang JH; Kim DS; Hong YK; Kim SH; Kang SG; Lang FF
    Childs Nerv Syst; 2013 Jan; 29(1):55-64. PubMed ID: 23143001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.